Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 789

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 789
---
 executed registration rights agreement dated October 9, 2024, or the Registration Rights Agreement, such that the Company Common Shares must be registered within 30 days of the closings. On October 10, 2024, the Company successfully implemented a crucial restructuring measure by converting the claims of debt holders in the amount of $ 2,788,650into 493,986Company Common Shares, (“Debt Conversion”) This conversion was facilitated through an ordinary capital increase, providing the necessary shares for the debt holders. This conversion was facilitated through an ordinary capital increase, providing the necessary shares for the debt holders, and was recorded at fair market value with no gain or loss recognized in the statement of operations. On October 9, 2024, the Company entered into the October SPA, with certain accredited investors and agreed to issue and sell to the investors, in a private placement offering, (i) 806,452Company Common Shares, and (ii) common share purchase warrants, or the Common Warrants, to purchase 806,452Company Common Shares, at a combined purchase price of $ 3.97, for aggregate gross proceeds of $ 3.2million. The Common Warrants have a term of fiveyears and have an exercise price of $ 4.25per share. Pursuant to the October SPA, the Company agreed to grant the investors the right to participate, in the aggregate, in up to fifty percent ( 50%) of future offerings for one yearfollowing the closing of the offering. In addition, the Company agreed not to enter into an equity line of credit or similar agreement, without the consent of the majority of the holders of the preferred shares. The transactions contemplated by the October SPA closed on October 10, 2024. On June 28, 2024, the Company entered into a securities purchase agreement for the issuance of 81,944Company Common Shares at a purchase price of $ 9.60per share. The offering closed on July 1, 2024. Investors also received unregistered warrants to purchase up to 81,944Company Common Shares at an exercise price of $ 9.60per share. These warrants are exercisable upon issuance and will expire five years from the date of issuance. The offering resulted in gross proceeds of $ 786,660. The net proceeds were used for working capital and general corporate purposes. H.C. Wainwright & Co., LLC served as the exclusive placement agent for the offering, or the Placement Agent. The